SRH NeuroRestorative Annual Medical Directors' Conference 2021: Archived
Program Description
This enduring activity will bring together Medical Directors at all NeuroRestorative facilities. It will address three areas of clinical practice that are among those confronted by NeuroRestorative Medical Directors: Chronic traumatic brain injury (TBI)/Aging with TBI, disorders of consciousness after TBI, and neuroendorcine disorders after TBI. Education about thse topics will inform clinical practice.
Target Audience
This activity is intended for Medical Directors (MDs, DOs), psychologists (PhDs, PsyDs), and nurse practitioners (NPs) who practice at NeuroRestorative facilities in 26 states across the United States.
Learning Objectives
Upon completion of this activity, participants will be able to:
1. Describe the medical, physical, psychological & social issues that arise as patients age with TBI
2. Summarize the guidelines for the evaluation & management of patients with disorders of consciousness
3. Describe the evaluation of neuroendocrine disorders for patients with TBI at different points in time following injury
Additional Information
Spaulding Rehabilitation Hospital, NeuroRestorative & Mass General Brigham
1:30 PM | Welcome & Introductions Mel Glenn, MD |
1:55 PM | Company Update Bill Duffy, President |
2:10 PM | EMR/Point Click Care Lu Sutherland, Vice President of Quality Improvement |
2:35 PM | New Guidelines for Patients with Disorders of Consciousness Joseph Giacino, PhD |
3:30 PM | Break |
3:45 PM | Endocrine Disorders Following Traumatic Brain Injury Seth Herman, MD |
4:15 PM | Chronic TBI / Aging with TBI Mel Glenn, MD |
5:00 PM | Closing Remarks Mel Glenn, MD |
5:05 PM | Adjournment |
Mel Glenn, MD - Course Director
Dr. Glenn earned his medical degree from New York University (NYU) School of Medicine. He completed his internship and residency in physical medicine and rehabilitation (PM&R) and then a fellowship in spinal cord injury medicine at NYU. In 1982 he joined the faculty of the Dept. of PM&R at Tufts University and the staff of its affiliates New England Medical Center Hospitals, New England Sinai Hospital (NESH), and Greenery Rehabilitation Center. He was Director of Rehabilitation Medicine at Greenery's Brain Injury Program, and then Director of the Brain Injury Program at NESH. From 1993 until 1998, he was Professor and Chairman of the Dept. of Rehabilitation Medicine at Boston University School of Medicine and Chief of Rehabilitation Medicine at Boston Medical Center, where he was the Project Director of the New England Regional Spinal Cord Injury Center's Spinal Cord Injury Model Systems grant. In 1998, he joined the staff of Spaulding Rehabilitation Hospital (SRH) as Director of Outpatient and Community Brain Injury Rehabilitation, and has since been made Chief, Division of Brain Injury for the Dept. of PM&R at SRH Network. He is an Associate Professor of PM&R and Associate Chair of the Brain Injury Division of the Dept. of PM&R at at Harvard Medical School (HMS). Dr. Glenn was Project Director of the Spaulding/Partners TBI Model System at HMS, a research grant funded by the National Institute on Disability and Rehabilitation Research, from 1998 to 2008. He has been Medical Director of Brain Injury Services in MA for Mentor ABI/NeuroRestorative since 1991 and Medical Director of Community Rehab Care since 1996. Dr. Glenn was the editor of the Update on Pharmacology column of Journal of Head Trauma Rehabilitation from 1985 to 2013.
Dr. Glenn has worked with NeuroRestorative’s Massachusetts program as medical director for more than 25 years. As National Medical Director, Dr. Mel Glenn works with our exceptional team of more than 70 medical directors across 26 states to enrich NeuroRestorative’s research, advocacy, and education initiatives throughout the country. Dr. Glenn supports NeuroRestorative’s sharing of best practices for clinical and medical management as well advocacy efforts aimed at enhancing access to personalized, measurable, quality care.
William Duffy
As president of NeuroRestorative, Bill directs the company’s strategic business planning and program development. Bill joined NeuroRestorative as chief operating officer in 2008. Prior to joining NeuroRestorative, Bill was the chief executive officer of Radius Specialty Hospital in Boston. He also served as chief executive officer for Commonwealth Communities, overseeing four rehabilitation hospitals across Massachusetts. Bill holds a bachelor’s degree in accounting from Stonehill College.
Joseph T. Giacino, PhD
Joseph T. Giacino, PhD is Professor of Physical Medicine and Rehabilitation at Harvard Medical School (HMS), and Director of Rehabilitation Neuropsychology, the Disorders of Consciousness Program and the Neurorehabilitation Laboratory at Spaulding Rehabilitation Hospital. He also holds appointments as a Neuropsychologist in the Department of Psychiatry at Massachusetts General Hospital, Adjunct Professor in the Rehabilitation Sciences Doctoral Program at the MGH Institute of Health Professions and teaches Neuroethics at the HMS Center for Bioethics. His research focuses on developing more precise neurodiagnostic procedures, clinical outcome assessment measures and therapies for persons with severe acquired brain injury. He is the Principal Investigator for the Spaulding-Harvard Traumatic Brain Injury Model System, Co-PI and Outcomes Core Lead for the TRACK-TBI Network and Co-PI on a Brain Initiative grant investigating Central Thalamic Stimulation for TBI. He co-chairs the NINDS TBI Common Data Element Steering Committee and is Past-President of the American Congress of Rehabilitation Medicine (ACRM). He led the expert panels that developed the minimally conscious state case definition and 2018 Practice Guideline Update on Disorders of Consciousness. Dr. Giacino has authored over 160 peer-reviewed publications and is the recipient of the ACRM BI-ISIG Lifetime Achievement Award, William Fields Caveness Award (BIAA, Inc) and Robert L. Moody Prize (University of Texas Medical Branch).
Seth Herman, MD
Seth Herman is a Physiatrist with a subspeciality in Brain Injury Medicine. He moved from Boston in April of 2020 to take on the position of Brain Injury Medical Director of California Rehabilitation Institute which is how I have known him. Prior to taking on this position; he was Director of Brain Injury Medicine Fellowship at Spaulding Rehabilitation Hospital within the Department of Physical Medicine and Rehabilitation at Harvard Medical School. He obtained his medical degree at Penn State and residency training at Shirley Ryan Ability Ability/Formerly known as Rehabilitation Institute of Chicago/Northwestern Medical School. His research and clinical interests are focused on the treatment and improvement of functional outcomes of those who suffered traumatic and acquired brain injuries as well as functional neurological disorders. He is interested in the evaluation and management of potential medical barriers that can impair functional outcomes such as poor sleep, pain, spasticity, neuro-endocrine dysfunction, neurobehavioral, cognitive, physical and emotional deficits. As a trained physiatrist, he has the expertise to understand the whole patient and the role of body system/structure deficits and impact on activity and participation.
LuAnn Sullivan, RN, MSN, PTA
As Vice President of quality improvement for NeuroRestorative, Lu provides leadership and direction to operations across the country. She joined NeuroRestorative in 2012 as vice president of quality and outcomes and has held positions overseeing operations, quality improvement, and clinical compliance for The MENTOR Network’s Adult Day Health Services. Prior to joining The Network, Lu held numerous leadership positions in healthcare, including vice president of clinical services at Senior Solutions HCM and chief clinical officer at Kindred N.E. Specialty Hospital.
Lu holds a bachelor’s in Nursing and is a registered nurse and physical therapist assistant currently enrolled in a master’s of science nursing program in health systems management. She is a board member of the Massachusetts Adult Day Services Association and a member of the American Association of Nurse Assessment Coordination and the Brain Injury Alliance.
FACULTY DISCLOSURE STATEMENTS
In accord with the disclosure policy of Mass General Brigham as well as guidelines of the Accreditation Council for Continuing Medical Education (ACCME), planners, speakers and anyone who may have an influence on the content of the activity have been asked to disclose any relationship they or their spouse/partner have to companies producing pharmaceuticals, medical equipment, devices, etc. that may be germane to the content of their presentation. Such disclosure is not intended to suggest or condone bias, but provides participants with information that might be of potential importance to their evaluation of a given presentation.
RESOLUTION OF CONFLICTS OF INTEREST (COI)
Mass General Brigham has implemented a process to resolve potential COIs for this CME activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.
The following planner and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:
Victoria Harding, PhD
LuAnn Sullivan, RN, MSN, PTA
The following planner and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:
Mel Glenn, MD
Stock: Marimed, Inc.
The following speakers and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:
Bill Duffy
Seth Herman, MD
Joseph Giacino, PhD
LuAnn Sullivan, RN, MSN, PTA
The following speakers and/or their spouse/partner have reported relevant financial relationship with a commercial interest:
Mel Glenn, MD
Stock: Marimed, Inc.
Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mass General Brigham designates this enduring activity for a maximum of 3.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
- 3.00 Participation